N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141763 |
| CAS No | 856068-98-9 |
| Mol.F. | C9H14N2O2 |
| Mol.Wt. | 182.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141764 |
| CAS No | NA |
| Mol.F. | C16H12Cl2N6O2S |
| Mol.Wt. | 423.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141765 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141766 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141767 |
| CAS No | NA |
| Mol.F. | C12H12N2O7 |
| Mol.Wt. | 296.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141768 |
| CAS No | NA |
| Mol.F. | C16H16FN5O6 |
| Mol.Wt. | 393.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141769 |
| CAS No | NA |
| Mol.F. | C16H17FN4O5 |
| Mol.Wt. | 364.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141770 |
| CAS No | NA |
| Mol.F. | C16H17FN4O5 |
| Mol.Wt. | 364.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141771 |
| CAS No | NA |
| Mol.F. | C15H15FN4O5 |
| Mol.Wt. | 350.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141772 |
| CAS No | NA |
| Mol.F. | C15H14F4N2O5 |
| Mol.Wt. | 378.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141773 |
| CAS No | NA |
| Mol.F. | C15H14FN3O5 |
| Mol.Wt. | 335.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141774 |
| CAS No | NA |
| Mol.F. | C20H22N8O8 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141775 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141776 |
| CAS No | NA |
| Mol.F. | C20H21N9O8 |
| Mol.Wt. | 515.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141777 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 |
| Mol.Wt. | 486.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141778 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 |
| Mol.Wt. | 486.4 |
| INV STATUS | CUSTOM SYNTHESIS |